BioXcel Therapeutics (BTAIQ) Total Debt (2017 - 2026)
BioXcel Therapeutics (BTAIQ) reported Total Debt of $104.45 million for Q2 2026, down 3.9% from $108.69 million a year earlier but up 4.2% from the prior quarter.
Powered by 
Analysis
BioXcel Therapeutics (BTAIQ) Total Debt (2017 - 2026) Analysis & Trends
At the end of FY2025, BioXcel Therapeutics posted Total Debt of $109.59 million, up 6.9% from FY2024.
- Total Debt has increased for three consecutive years, with a three-year compound annual growth rate of 5.6% (FY2022 to FY2025).
- By year, Total Debt came in at $102.51 million in FY2024 (+1.9%), $100.6 million in FY2023 (+8.1%) and $93.05 million in FY2022.
- Five-year quarterly Total Debt spans a low of $61.08 million in Q2 2022 and a high of $109.59 million in Q4 2025.
- Year over year, Total Debt gained in six of the last eight quarters, with growth averaging 2.4%.
- The high point for year-over-year Total Debt in five years was Q2 2023 (growth of 58.6%); the low point was Q1 2026 (a decline of 5.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $100.29 million (Q1 2026), $109.59 million (Q4 2025) and $109.13 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 49.04 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 70.82 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 53.91 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 37.49 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -111.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 57.30 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 26.25 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 63.19 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | - |
| 10 | BioXcel Therapeutics | 1.57 Mn | 1.57 Mn | 160,000.00 | 104.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 104.45 Mn |
| Mar 31, 2026 | 100.29 Mn |
| Dec 31, 2025 | 109.59 Mn |
| Sep 30, 2025 | 109.13 Mn |
| Jun 30, 2025 | 108.69 Mn |
| Mar 31, 2025 | 105.53 Mn |
| Dec 31, 2024 | 102.51 Mn |
| Sep 30, 2024 | 104.44 Mn |
| Jun 30, 2024 | 103.01 Mn |
| Mar 31, 2024 | 101.63 Mn |
| Dec 31, 2023 | 100.60 Mn |
| Sep 30, 2023 | 99.09 Mn |
| Jun 30, 2023 | 96.85 Mn |
| Mar 31, 2023 | 95.06 Mn |
| Dec 31, 2022 | 93.05 Mn |
| Sep 30, 2022 | 91.70 Mn |
| Jun 30, 2022 | 61.08 Mn |
| Dec 31, 2017 | 371,000.00 |
API Access
BioXcel Therapeutics Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=BTAIQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "BTAIQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();